диссертации / 40

111

78.Lingam S, Newton R. Right from the start. Paediatric practice guidelines. Edinburgh: British Paediatric Association; 1996;

79.Look, A. T. A leukemogenic twist for GATA1. Nature Genet. 32: 83-84, 2002. [PubMed: 12172549, related citations] [Full Text: Nature Publishing Group]

80.Loudon M. M, Day RE, Duke EMC .Thyroid dysfunction in Down's syndrome.// Archives of Disease in Childhood.-1985- 60-р.1149-1151.

81.Lyle, R., Bena, F., Gagos, S., Gehrig, C., Lopez, G., Schinzel, A., Lespinasse, J., Bottani, A., Dahoun, S., Taine, L., Doco-Fenzy, M., Cornillet-Lefebvre, P., and 16 others. Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21// Europ. J. Hum. Genet. – 2009.- 17- р.454-466.

82.Mannan S. E., Ejaz Y., Hossain J. Prevalence of positive skinprick test results in children with Down syndrome: a case control study// Ann Allergy Asthma Immunol.2009.- 102- р. 2005–2009

83.Marcus C.L., Keens T.G., Bautista D.B., von Pechmann W.S., Ward S.L. Obstructive sleep apnea in children with Down syndrome// Pediatrics.- 1991 - 88(1)- р.132-139.

84.Margar-Bacal F. et al. Speech intelligibility after partial glossectomy in children with Down's syndrome// Plastic and Reconstr Surg.-1987.- 79-

р. 44-47.

85.Matsuyama N., Ito Y. The frequency of fingerprint type in parents of children with Trisomy 21 in Japan// Journal of Physiological Anthropology. -2006.- 25(1)- р.15-21.

86.Mc Cormick M., Schinzel A., Petersen M., Stetten G., Driscoll D., Cantu E., Tranebjaerg L., Mikkelsen M., Watkins P., Antonarakis S. Molecular genetic approach to the characterization of the Down syndrome region of chromosome 21// Genomics.-1989.- 5 –р.325-331.

112

87.Mc Elhinney D.B., Straka M., Goldmuntz E., Zackai E.H. Correlation between abnormal cardiac physical examination and echocardiographic findings in neonates with Down syndrome// Am J Med Genet. – 2002.-

113(3)- р.238-241.

88.Mikkelsen M. Down's syndrome cytogenetic epidemiology. Hereditas. 1977.-86р. 45-59. [электронный ресурс PubMed: 143464, related

citations]

89.Milbrandt T.A., Johnston C.E. Down syndrome and scoliosis: a review of a 50-year experience at one institution// Spine.- 2005.- 30(18)-р.2051-

2055.

90.Miller M., Cosgriff J.M. Hematologic abnormalities in newborns with

Down’s syndrome// Journal of Medical Genetics.- 1973- 1-р. 173-179.

91.Mundschau, G., Gurbuxani, S., Gamis, A. S., Greene, M. E., Arceci, R. J., Crispino, J. D. Mutagenesis of GATA1 is an initiating event in Down

syndrome leukemogenesis. Blood 101: 4298-4300,

2003. [PubMed: 12560215, related citations] [Full Text: HighWire Press]

92.Nakamura A., Hattori M., Sakaki Y. Isolation of a novel human gene from the Down syndrome critical region of chromosome 21q22.2// J. Biochem.-

Edinburgh: Churchill Livingstone.- 1992.-p. 21–35

94.Olbrisch R.R. Plastic and aesthetic surgery on children with Down's syndrome// Aesth Plast Surg.- 1985.- 9-р.241-248.

95.Parsons C.L.et al. Effect of tongue reduction on articulation in children with Down syndrome// Amer J Mental Defic.-1987.- 91- р.328-332.

96.Penrose L. S.The relative effects of paternal and maternal age in mongolism// Journal Genetics. – 1933.- 27-р. 219.

97.Petersen M. B., Adelsberger P. A., Schinzel A. A., Binkert F., Hinkel G.

113

K., Antonarakis S. E. Down syndrome due to de novo Robertsonian translocation t14;21: DNA polymorphism analysis suggests that the origin of the extra 21q is maternal// Am. J. Hum. Genet.-1991.- 49- р. 529-536.

98.Piro E, Pennino C, Cammarata M, et al. Growth charts of Down syndrome children in Sicily: evaluation of 382 children 0–14 years of age// Am J Med Genet Suppl.- 1990.- 7- р.66–70.

99.Prasher V.P . Overweight and obesity amongst Down’s syndrome adults //

J. Intellectual Disability Res. -1995-(3) р.437-441.

100.Pueschel S.M. Clinical aspects of Down syndrome from infancy to adulthood// Issues Law Med. -1989.- 5(1)- р.87-99.

101.Pueschel S.M., Schola F.H. Atlantoaxial instability in individuals with Down syndrome: epidemiologic, radiographic and clinical studies// Pediatrics.- 1987.- 80- р. 555-560.

102.Pueschel S.M., Scola F.H. Atlantoaxial instability in individuals with Down syndrome: epidemiologic, radiographic, and clinical studies// Pediatrics. -1987- 80(4)- р.555-560.

103.Pueschel S.M., Scola F.H., Perry C.D., Pezzullo J.C. Atlanto-axial instability in children with Down syndrome// Pediatric Radiology.- 1981.- 10(3)-р.129-132.

104.Pueschel S.M., Scola F.H., Pezzullo J.C. A longitudinal study of atlantodens relationships in asymptomatic individuals with Down syndrome// Paediatrics.- 1992.- 89 - р. 1194-1198.

105. Pueschel S.M., Anneren G., Durlach R., Flores J., Sustrova M., Verma I.C.. Guidelines for optimal medical care of persons with Down syndrome // Acta Paediatr. -1995-84- р.823–827.

106.Quinn M.W. Down's syndrome and hypothyroidism // Ir J Med Sci.- 1980.- 149- р. 19-22.

107.Rajangam S., Janakiram S., Thomas I.M. Dermatoglyphics in Down's syndrome// Journal of the Indian Medical Association. -1995.- 93(1)-р.

114

10-3.

108.Ranke M.B. Disease specific growth charts, do we need them?// ActaPaediatr Scand Suppl.- 1989.- 356- р.17–25.

109.Rex A. P., Preus M. A diagnostic index for Down syndrome// J. Pediatr.-1982.- 100- р. 903-906. [PubMed: 6211531, related citations]

110.Roizen N.J., Patterson D. Down’s syndrome// Lancet.-2003.-361-

р.1281–1289.

111.Roizen N.J., Mets M.B., Blondis T.A . Ophthalmic Disorders in Children with Down Syndrome // Developmental Medicine and Child Neurology.-1994 – 36- р.594-600.

112.Sare Z., Ruvalcaba R.H.A., Kelley V.C. Prevalence of thyroid disorders in Down syndrome // Clin Genetics.- 1978.- 14- р. 154-158.

113.Selikowitz M. A five-year longitudinal study of thyroid function in children with Down syndrome // Dev. Med. Child Neurol.-1993.- 35-

р.396-401.

114.Shaw C.K., Thapalial A., Nanda S., Shaw P. Thyroid dysfunction in Down syndrome// Kathmandu Univ Med J (KUMJ). -2006.- 4(2)- р.182186.

115.Shaw E.D., Beals R.K. The hip joint in Down's syndrome. A study of its structure and associated disease// Clinical orthopedics and related research. -1992. -278- р.101-107.

116.Spender Q., Stein A., Dennis J., Reilly S., Percy E., Cave D. An exploration of feeding difficulties in children with Down syndrome //Dev Med Child Neurol. -1996-38- р.681–694.

117.Stafstrom C.E, Konkol R.J. Infantile spasms in children with Down syndrome// Developmental medicine and child neurolody. -1994.- 36(7)-

р.576-585.

118. Stafstrom C.E. Epilepsy in Down syndrome: clinical aspects and possible mechanisms// American journal of mental retardation. -1993.- 98-

115

р.12-26.

119. Stebbens V.A., Samuels M.P., Southall D.P., Dennis J., Croft C.B. Sleep related upper airway obstruction in a cohort with Down's syndrome.

//Arch Dis Child. -1991- 66- р. 1333–1338.

120.Stephen E., Dickson J., Kindley A.D. et al. Surveillance of vision and ocular disorders in children with Down syndrome// Dev Med Child Neurol.-2007.- 49- р.513–515.

121.Styles M.E., Cole T.J., Preece M.A., Dennis J. New cross sectional stature, weight and headcircumference references for Down’s syndrome in

the UK and Republic of Ireland.//Arch Dis Child.- 2002-87- р. 104-108.

122.Susan N. Van Cleve, William I. Cohen, M.D.Part I: Clinical Practice Guidelines with Down Syndrome from sirth to 12 years// Journal of Pediatric Health Care. -2006.-р.47-54.

123.Suzanne B. Cassidy, M.D. Judith E. Allanson, M.D. Management of genetic Syndromes. 2-nd ed. -2005– P. 191–210.

124.Swigonski N.L., Kuhlenschmidt H.L., Bull M.J., Corkins M.R., Downs S.M. Screening for celiac disease in asymptomatic children with Down syndrome: cost-effectiveness of preventing lymphoma// Pediatrics. -2006

.-118(2)- р.594-602.

125.Takahashi H., Bordy M.D., Sharma V., Grunt J.A. Hyperthyroidism in patients with Down's syndrome.//Clinical paediatrics.-1979- 18- р.273 - 275.

126.Tandon, R., Edwards, J. E. Cardiac malformations associated with Down's syndrome.// Circulation .-1673-47-р. 1349-1355.

127.Thuline H. C., Pueschel S. M. Cytogenetics in Down syndrome. In: Pueschel S. M.; Rynders J. E. : Down Syndrome. Advances in Biomedicine and the Behavioral Sciences. Cambridge: Ware Press (pub.).- 1982.- р. 133.

128.Torrado C., Bastion W., Wisniewski K.E., Castells S . Treatment of

116

children with Down’s syndrome and growth retardation with recombinant

human growth hormone //J Pediatr.-1991.- 119 (3)- р.478-83

129.Traboulsi E.I., Levine E., Mets M.B., Parelhof E.S., O’Neill J.F., Gaasterland DE .Infantile glaucoma in Down’s syndrome (trisomy 21)// American Journal of Ophthalmology.-1982.- 105- р. 389-394.

130.Tubman T.R.J., Shields M.D., Craig B.G., Mullholland H.C., Nevin N.C. Congenital heart disease in Down's syndrome: two year prospective early screening study// BMJ. -1991-302-р.1425–1427.

131.Unachak K., Tanpaiboon P., Yupada Pongprot Y. et al. Thyroid

functions in children with Down’s syndrome// J Med Assoc Thai.- 2008.-

91- р.56–61.

132.Van Trotsenburg A.S., Vulsma T., van Rozenburg-Marres S.L., van Baar A.L., Ridder J.C., Heymans H.S., Tijssen J.G., de Vijlder J.J. The effect of thyroxine treatment started in the neonatal period on development and growth of two-year-old Down syndrome children: a randomized clinical trial// J Clin Endocrinol Metab. -2005.-90(6)- р.3304-11.

133.vanWouwe J.P., Siderius E.J., Borstlap R. et al. Optimalmedical care for children with Down syndrome and their parents // Ned Tijdschr Geneeskd.-2001.- 145.- р.1617–1621.

134.Vidal-Taboada J. M., Sanz S., Egeo A., Scartezzini P., Oliva R. Identification and characterization of a new gene from human chromosome 21 between markers D21S343 and D21S268 encoding a leucine-rich protein // Biochem. Biophys. Res. Commun. -1998.-250-р.

547-554.

135.Vis J.C., Duffels M.G.J., Winter M.M. et al. Down syndrome: a cardiovascular perspective // J Intellect Disabil Res.-2009.- 53- р.419–425.

136.Wechsler J., Greene, M., McDevitt M. A., Anastasi, J., Karp J. E., Le

Beau M. M., Crispino J. D. Acquired mutations in GATA1 in the

megakaryoblastic leukemia of Down syndrome// Nature Genet.- 2002.-

117

32- р.148-152, 2002. [PubMed: 12172547, related citations] [Full

Text:Nature Publishing Group]

137.Weijerman M.E., van Furth A.M., Vonk Noordegraaf A. et al. Prevalence, neonatal characteristics and first-year mortality of Down syndrome: a national study // Journal Pediatrics.- 2008.- 152- р.15–19.

138.Weinstein H.S.Congenital leukemia and the neonatal myeloproliferative

disorders associated with Down’s syndrome.//Clin. Haematol.- 1978.- 7-р.

147-156.

139.Wertelecki W.: Dermatoglyphics. In:Human Malformations and Related Anomalies, vol II, Oxford Monographs on Medical Genetics No.27, Oxford University Press, New York.- 1993.- p.999-1016.

140.Werthiem К. The fingerprint sourcebook. Chapter 3: Embriology and morphology of friction ridge skin. National Institute of Justice.-2002.- p.52-76.

141.Wexler M.R. et al. Rehabilitation of the face in patients with Down syndrome // Plastic and ReconstrSurg.-1986.- 77- р.383-393.

142.Wong V., Ho D. Ocular abnormalities in Down syndrome: an analysis of 140 Chinese children // PediatrNeurol.-1997.- 16-р.311–314.

143.Wouters J., Weijerman M.E., van Furth A.M. et al. Prospective HLA, EMA, and TGA testing celiac disease in children with Down syndrome // J Pediatrics.-2009.- 154 р.239–242.

144.Wouters J., Weijerman M.E., van Furth A.M., Schreurs M.W., Crusius J.B., von Blomberg B.M., de Baaij L.R., Broers C.J., Gemke R.J.Prospective human leukocyte antigen, endomysium immunoglobulin A antibodies and transglutaminase antibodies testing for celiac disease in children with Down syndrome // J Pediatr. -2009 -154(2)- р.239-242.

145.Wren C., Richmond S., Donaldson L . Presentation of congenital heart disease in infancy:implications for routine examination//Arch.Dis.Child.Fetal Neonatal Ed- 1993.-. 80-р. 49-50.

118

здравоохранения].

147.Yamaki S.,Yasui H., Kado H., Yonenaga L. et al. Pulmonary vascular disease and operative indications in complete atrioventricular canal defect. J.Thoracic Cardiovascular Surgery. -1993.-106- р.398-405.

148.Yang Q., Rasmussen S.A., Friedma J.M. Mortality associated with

Down’s syndrome in the USA from 1983 to 1997: a population-based study// Lancet.-2002.- 359- р.1019–1025.

149. Zipursky A., Peeters M., Poon, A. Megakaryoblastic leukemia and Down syndrome-A review.In: McCoy, E. E.; Epstein, C. J. : Oncology and Immunology of Down Syndrome. New York: Alan R. Liss (pub.)- 1987.- p. 33-56.

119

ПРИЛОЖЕНИЕ

Приложение

Рисунок 1. Перцентильные графики массы тела девочек с СД первого

года жизни.

120

Рисунок 2. Перцентильные графики массы тела мальчиков с СД

первого года жизни.